Home / News / Press Releases
News & Updates— Press Releases

News & Updates Press Releases

Veos Pharmaceuticals Participating in Smart Energy Week Autumn 2025 Business Mission — Veos Pharmaceuticals.

Back to all press releases
Event August 21, 2025 Madrid, Spain

Veos Pharmaceuticals Participating in Smart Energy Week Autumn 2025 Business Mission

OliQuell™, our natural solution for environmental remediation, has been selected for the Smart Energy Week Autumn 2025 Business Mission in Japan.

Exciting news from Veos Pharmaceuticals! 🇯🇵⚡

We are honored to announce that OliQuell™, our natural solution for environmental remediation, has been selected for the Smart Energy Week Autumn 2025 Business Mission in Japan, organized by the EU Business Hub.

OliQuell™ is a breakthrough platform derived from olive waste that naturally captures CO₂ and neutralizes toxic industrial gases — an ideal fit for Japan's sustainability and decarbonization goals.

A Unique Opportunity

This is a unique opportunity for us to:

We are excited to bring Mediterranean innovation to Japan's global clean tech stage. Stay tuned as we share insights, updates, and impact from this mission.

Partners & Collaborators

With thanks to our partners and collaborators on this mission:

#OliQuell #SmartEnergyWeek #EUBusinessHub #CarbonRemoval #GreenInnovation #Decarbonization #EUJapan #VeosPharma #CleanTech #ClimateAction #CO2Capture #NatureBasedSolution

About Veos Pharmaceuticals

Headquartered in Madrid, Spain, Veos Pharmaceuticals S.L. is a global biotechnology company with a portfolio of nearly 40 products across the EU, US, and Canada. The company specializes in OTC solutions, biostimulants, and advanced nutritional products aimed at improving quality of life.

Veos Pharma's flagship products include Ocufresh®, BioPropello™, OliQuell™, OleoSorb™, VEOX-Preserve™, and ThymoTropin™.

For more information, visit www.veospharma.com.

Share: in 𝕏 @

Media & Investor Contact

Veos Pharmaceuticals, S.L.
Calle Núñez de Balboa, 35 A-5 Planta Oficina A1
28001 Madrid, Spain
Email: info@veospharma.com
Telephone: +34 911 925 649
Website: www.veospharma.com

Forward-Looking Statements. This announcement may include forward-looking statements based on current expectations and involving risks and uncertainties. Actual results may differ materially. Veos Pharmaceuticals assumes no obligation to update or revise these statements after the date of publication.